Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02497534 · ClinicalTrials.gov registry record
Biomarkers in Friedreich's Ataxia
A clinical trial of Friedreich's Ataxia, sponsored by University of Florida.
- Recruiting
- Registry status
- 203
- Enrollment target
- 1
- Study location
NCT02497534: Recruiting study of Friedreich's Ataxia, sponsored by University of Florida.
NCT02497534 is a study of Friedreich's Ataxia that is actively recruiting participants, run by University of Florida. The registered enrollment target is 203 participants, above the 40-participant average among 5 other Friedreich's Ataxia trials with a reported enrollment target (408% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02497534, a study of Friedreich's Ataxia, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- 203 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to characterize measures of cardiac performance and neuromuscular physiology in FA patients using novel techniques, including echocardiography and magnetic resonance imaging (MRI), metabolic exercise testing, and neurophysiological outcomes.
Primary Outcome
Cardiac MRI will be used to characterize cardiac morphology and function.
Conditions Studied
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2015-09 |
| Est. Completion | 2030-06-03 |
What NCT02497534 shows while recruiting
NCT02497534 is an observational study that tracks outcomes without assigning an intervention. The registered 203 participants enrollment target is mid-sized for trials with a published cap, above the 40-participant average among 5 other Friedreich's Ataxia trials with a reported enrollment target (408% higher).
The record links to 1 condition, with Friedreich's Ataxia appearing as the primary indexed condition, and to 0 interventions.
NCT02497534 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02497534 about?
NCT02497534 is a clinical study titled "Biomarkers in Friedreich's Ataxia". The purpose of this project is to characterize measures of cardiac performance and neuromuscular physiology in FA patients using novel techniques, including echocardiography and magnetic resonance imaging (MRI), metabolic exercise testing, and neurophysiological outcomes.
What is the current status of trial NCT02497534?
This trial is currently recruiting. The enrollment target is 203 participants. The study started on 2015-09. Estimated completion is 2030-06-03.
What conditions does trial NCT02497534 study?
This clinical trial studies the following conditions: Friedreich's Ataxia.
Who is sponsoring clinical trial NCT02497534?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02497534 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Friedreich's Ataxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
RECRUITING
-
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
COMPLETED · Phase 1
-
EPI-743 in Friedreich's Ataxia Point Mutations
COMPLETED · Phase 2
-
A First in Human Study of RT001 in Patients With Friedreich's Ataxia
COMPLETED · Phase 1
-
Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND)
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05652686 · 203 participants · Phase 1
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- NCT06063122 · 203 participants · NA
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
- NCT07031245 · 203 participants · NA
Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia